Sharp decline in investments in Israel's life sciences industry in 2025
A new report published recently points to significant changes in the Israeli Health-Tech industry. After a year of recovery in 2024, the industry is now facing new and significant economic challenges.
According to the data, there was a sharp 40% decline in investments in Israeli life sciences companies during 2025. This is a concerning figure for the sector, which is considered one of the most important growth engines of the Israeli economy.
In addition to the overall decline in the volume of investments, the report points to a continuing trend of a decrease in the average amount of each deal. This means that companies in the field are finding it more difficult to raise large sums as was customary in the past.
Despite the challenging data regarding investments, the report notes that stability was recorded in the exports of life sciences companies. This figure indicates that the products and services of Israeli companies are still in high demand in international markets.
The industry is now examining how to continue to grow under the changing market conditions. Experts are closely monitoring these trends to understand whether this is a temporary change or a prolonged period of slowdown in investments in the health and technology sector.